AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen

By Jamie Lennox ( February 10, 2026, 6:40 PM GMT) -- AstraZeneca subsidiary Alexion has settled its claims in the U.K. that Samsung and Amgen infringed a patent covering blood disease drug Soliris, closing the case several months after the Court of Appeal refused to block sales of the defendants' biosimilar drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login